Evidence map›Paper›PMID 22955916›Full record

ArticleBlood2012

PTH expands short-term murine hemopoietic stem cells through T cells.

Jau-Yi Li, Jonathan Adams, Laura M Calvi, Timothy F Lane, Richard DiPaolo, M Neale Weitzmann, Roberto Pacifici

Open access · bronzeAbstract readEvaluation Study
In one paragraph

Article in Blood, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Review
  3. The role of WNT10B in physiology and disease: A 10-year update.Frontiers in cell and developmental biology · 2023
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Insensitive to PTH of CD8International journal of medical sciences · 2020
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Role of Vitamin D in Uremic Vascular Calcification.BioMed research international · 2017
    Review
  16. JAK2Leukemia · 2016
    Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Jau-Yi LiDivision of Endocrinology, Metabolism and Lipids, Department of Medicine, Emory University, Atlanta, GA 30322, USA.
Jonathan Adams
Laura M Calvi
Timothy F Lane
Richard DiPaolo
M Neale Weitzmann
Roberto Pacifici
Emory University · USOrthopaedic Hospital · USSaint Louis University · USUniversity of Rochester · US

Funding

UNIVERSITY OF ROCHESTER'S RESEARCH ASSOCIATE ORGANIZATIONUL1RR024160 · NCRR · UNIVERSITY OF ROCHESTER · PI PEARSON, THOMAS ARTHUR · 2006 to 2011
$38.7M
Universiity of Rochester Center for Medical Countermeasures against RadiationU19AI091036 · NIAID · UNIVERSITY OF ROCHESTER · PI CHEN, YUHCHYAU · 2010 to 2014
$15.6M
T CELLS AND PTH INDUCED BONE LOSSR01AR054625 · NIAMS · EMORY UNIVERSITY · PI PACIFICI, ROBERTO · 2007 to 2016
$3.3M
Effect of HIV Infection and HAART on Bone HomeostasisR01AR059364 · NIAMS · EMORY UNIVERSITY · PI OFOTOKUN, IGHOVWERHA, WEITZMANN, MERVYN NEALE · 2009 to 2013
$3.2M
Bone Loss and Immune Reconstitution in HIV/AIDSR01AG040013 · NIA · EMORY UNIVERSITY · PI OFOTOKUN, IGHOVWERHA, WEITZMANN, MERVYN NEALE · 2011 to 2015
$2.8M
Regulation of T Cell TNF ProductionR01AR049659 · NIAMS · EMORY UNIVERSITY · PI PACIFICI, ROBERTO · 2002 to 2012
$2.8M
Regulation of hemopoietic stem cell expansion by calciotrophic hormonesR01DK091780 · NIDDK · EMORY UNIVERSITY · PI PACIFICI, ROBERTO · 2011 to 2014
$1.5M
Biological Actions and Cellular Targeting of Nanoparticles for Medical ApplicatioR01AR056090 · NIAMS · EMORY UNIVERSITY · PI BECK, GEORGE R., WEITZMANN, MERVYN NEALE · 2008 to 2010
$984k
B Cell OPG Production in Bone HomeostasisR21AR053607 · NIAMS · EMORY UNIVERSITY · PI WEITZMANN, MERVYN NEALE · 2007 to 2008
$358k
Immune Regulation of Bone HomeostasisI01BX000105 · VA · VETERANS HEALTH ADMINISTRATION · PI WEITZMANN, MERVYN NEALE · 2009 to 2022
–
BLRD VA I01 BX000105NCRR NIH HHS UL1 RR024160NIAID NIH HHS U19 AI091036NIAMS NIH HHS AR053607NIAMS NIH HHS AR056090NIAMS NIH HHS AR059364NIAMS NIH HHS AR49659NIAMS NIH HHS AR54625NIAMS NIH HHS R01 AR049659NIAMS NIH HHS R01 AR054625NIAMS NIH HHS R01 AR056090NIAMS NIH HHS R01 AR059364NIAMS NIH HHS R21 AR053607NIA NIH HHS AG040013NIA NIH HHS R01 AG040013NIDDK NIH HHS DK091780NIDDK NIH HHS R01 DK091780
6 · The paper itself

Abstract

Intermittent parathyroid hormone (iPTH) treatment expands hemopoietic stem and progenitor cells (HSPCs), but the involved mechanisms and the affected HSPC populations are mostly unknown. Here we show that T cells are required for iPTH to expand short-term HSPCs (ST-HSPCs) and improve blood cell engraftment and host survival after BM transplantation. Silencing of PTH/PTH-related protein receptor (PPR) in T cells abrogates the effects of iPTH, thus demonstrating a requirement for direct PPR signaling in T cells. Mechanistically, iPTH expands ST-HSPCs by activating Wnt signaling in HSPCs and stromal cells (SCs) through T-cell production of the Wnt ligand Wnt10b. Attesting to the relevance of Wnt10b, iPTH fails to expand ST-HSPCs in mice with Wnt10b(-/-) T cells. Moreover, iPTH fails to promote engraftment and survival after BM transplantation in Wnt10b null mice. In summary, direct PPR signaling in T cells and the resulting production of Wnt10b play a pivotal role in the mechanism by which iPTH expands ST-HSPCs. The data suggest that T cells may provide pharmacologic targets for HSPC expansion.

Indexed as

AnimalsBone Marrow TransplantationCell ProliferationCells, CulturedCell SurvivalFemaleGenes, T-Cell Receptor betaHematopoietic Stem CellsHematopoietic Stem Cell TransplantationMiceMice, Inbred C57BLMice, KnockoutParathyroid HormoneTime FactorsT-LymphocytesWnt ProteinsParathyroid HormoneWnt10b protein, mouseWnt Proteins

Identifiers

PMID22955916
PMCPMC3507144
OpenAlexW2026290874

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.